In lung cancer, expression of EPCR has been proven to increase chemosensitivity, while in colorectal cancer such effects were not observed as the overexpression of EPCR was accompanied by expression of neighboring chemoresistance genes on chromosome 20q [41]. This evidence concerns the gene PROCR and lung cancer.